Trial Of Personalised Care After Treatment - Prostate Cancer: a pilot study

Bangor University (UK)0 个研究点目标入组 120 人开始时间: 2013年9月20日最近更新: 2019年2月11日

适应症

试验速览

•1. Stable, incident prostate cancer patients in BCUHB (defined as being 9-24 months post-diagnosis) in NE Wales
•2. Considered fit for taking part in the trial, as assessed by their multi-disciplinary team (MDT)
•3. Having undertaken radical curative therapy for prostate cancer (surgery, radiotherapy, or brachytherapy), or being followed up with PSA monitoring and symptom reporting (watchful waiting)
•4. All patients will have the ability to give informed consent, as assessed by the MDT

•1. Men who are in the Active Surveillance group (men who are suitable for active treatment, but choose to be monitored until proof of progression)
•2. Men who are clearly in the palliative phase
•3. Men who are deemed to be unable to take part in the trial (e.g., severe learning disability)
•4. Men who have active symptoms of severe enduring mental health problems, preventing patients from successfully participating in research studies (as assessed by the MDT)
•5. Men who do not have capacity to give informed consent

发起方

Bangor University (UK)